PVALB, parvalbumin, 5816

N. diseases: 148; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.060 AlteredExpression phenotype BEFREE We show that treatment aimed at preventing PV interneurons from becoming hyperexcitable is sufficient to restore PV interneuron properties to wild-type levels, reduce inhibitory input onto pyramidal cells, and rescue memory deficits in APP/PS1 mice. 31431685 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.060 Biomarker phenotype BEFREE The spatial T-maze identifies learning and memory deficits that are related to loss of CA3 pyramidal neurons and fewer parvalbumin-positive interneurons independent of putamen injury. 31009645 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.060 GeneticVariation phenotype BEFREE Sex-specific spatial memory deficits in mice with a conditional TrkB deletion on parvalbumin interneurons. 31150746 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.060 Biomarker phenotype BEFREE Finally, optogenetically suppressing PV interneurons rescued the memory impairment caused by removal of PNNs. 31843906 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.060 Biomarker phenotype BEFREE These results support the role of slow gamma oscillations in memory and suggest that optogenetic stimulation of medial septal parvalbumin neurons at 40 Hz could provide a novel strategy for treating memory deficits in AD. 31757962 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.060 Biomarker phenotype BEFREE Recent findings show that parvalbumin (PV) interneuron function is impaired in Alzheimer's disease (AD), and that this impairment in PV function can be linked to network dysfunction and memory deficits. 30273829 2018